James Lovgren
Chief Executive Officer & Co-Founder,
Aspiro Therapeutics
United States
I am an accomplished life science executive with a distinguished track record of commercializing disruptive technologies and managing industry-leading global product portfolios in excess of $250M. Businesses under my leadership have benefited from consistent revenue growth, increased profit margins, and expanded market share.
As the CEO of Aspiro Therapeutics, I am dedicated to leading the charge in developing groundbreaking treatments for obstructive lung diseases. With over a decade of experience in biotech, my focus is on advancing our lead candidate, a CC16 peptidomimetic, through preclinical development with a clear path toward clinical trials. I am committed to building strategic partnerships, securing funding, and driving our mission to bring life-changing therapies to patients worldwide.
Suffix
MBA
Sessions
-
10-Feb-2025Aspiro Therapeutics
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}